Introducing Our Cutting-Edge Analogue Tool: Forecasting with Precision and Insight

Introducing Our Cutting-Edge Analogue Tool: Forecasting with Precision and Insight

Forecasting Analogue Tool

In the pharmaceutical forecasting world, accurate and timely data is the cornerstone of strategic decision-making. Understanding the trajectory of a new drug—its market share potential, uptake patterns, and competitive landscape—is critical at every stage of its lifecycle. To meet these needs, we’re excited to unveil our new Analogue (Analog) Tool, created by forecasting experts, specifically for forecasters.

Designed by Experts, for Experts

Our Analogue Tool stands out because it’s designed by professionals who truly understand the challenges faced by forecasting teams. We know the pressure to make informed decisions quickly, the need for transparency in data, and the importance of having access to reliable, patient-level data. This tool is a product of deep industry insight, ensuring it addresses the specific needs and pain points of forecasters.

‘We have tried to build our own analogue database, but this was very difficult and took us years. The J+D tool will be extremely valuable for us, especially the fact that it is based on treated patients.’

The Role and Value of our Analogue Library

At the heart of our tool is a comprehensive analogue library that offers unmatched value and insight for forecasters. The analogue library is not just a collection of data; it’s a powerful resource designed to:

  • Improve Validation:

    By offering a rich selection of analogues, forecasters can better validate their models and assumptions.

  • Increase Forecast Confidence and Accuracy:

    With access to up to 2,000 oncology analogues covering 20 specific oncology indications across major countries, forecasters can draw from a vast pool of Evaluate data.

  • Enhance Transparency:

    The tool’s design emphasises transparency, providing a clear and comprehensive overview of the methodology and calculations underpinning the analogue selection.

  • Improve Consistency:

    With a robust methodology and standardised approach to analogue selection, our tool ensures that your forecasts are consistent across different products and markets.

Unmatched Data Depth and Relevance

One of the primary advantages of our Analogue Tool is its robust data foundation. Unlike other tools that rely on volume or revenue data, our platform is built on patient-level data. This distinction is crucial for forecasters aiming to integrate analogues into patient-based forecast models, as it provides more relevant and actionable insights.

Our tool also boasts an extensive range of indications, therapeutic areas (TAs), and unique drug profiles. This means you have access to a broader selection of analogues, allowing for more precise and tailored forecasting. Whether you’re dealing with a rare disease or a highly competitive oncology market, our tool offers the depth and flexibility you need to find the most relevant analogues.

Advanced Filtering for Precision

To make the most of this vast analogue library, our tool includes 30 advanced filters that allow you to drill down to the most relevant analogues quickly and efficiently. Whether you need to focus on a specific patient subgroup, market conditions, or drug class, these filters help you refine your selection, ensuring that the analogues you choose are the best possible match for your forecasting needs.

The tool’s dynamic charting feature visually represents your selected analogues, updating in real-time as you adjust filters and selections. This immediate feedback ensures you have a clear view of which analogues are driving your forecast, helping you make informed decisions with ease.

‘This library will really help us at all stages of our forecasting – early stage, launch prep and in market forecasts – to help us ‘tell the story’ surrounding our forecast inputs and outputs.’

Flexibility and User-Friendly Interface

Forecasting is complex enough without having to wrestle with complicated tools. That’s why we’ve made sure our Analogue Tool is as user-friendly as possible.


Whether you choose to use a single analogue or a combination of multiple analogues, the generated outputs can be dropped directly into your existing forecast models, streamlining the workflow and allowing you to focus on strategic analysis rather than data manipulation.

Dynamic and Actionable Insights

Whether you’re in the early stages of product planning, preparing for a launch, or managing a product’s lifecycle, our tool adapts to your needs.

  • Early Stage Planning:

    Use analogues to quickly estimate peak market share and sales potential, guiding your investment decisions and helping you assess the likely success of your new product.

  • Launch Readiness:

    Build accurate projections for market penetration and peak share in the crucial first 18 to 24 months following a product launch. This enables you to prepare operationally and set realistic expectations.

  • Events-Based Planning:

    Understand the impact of future events, such as loss of exclusivity, competitor launches, or new formulations, on your product’s market performance.

By combining multiple analogues, you can create weighted, constructed scenarios that more accurately reflect your forecast needs, reducing guesswork and providing reassurance in the accuracy of your projections.

Key Benefits for Forecasters

Our Analogue Tool delivers several key benefits that set it apart from the competition:

  • Accuracy and Transparency:

    Our platform ensures that every forecast is underpinned by robust, transparent data, enhancing the credibility of your projections.

  • Time and Resource Efficiency:

    By streamlining the process of finding and analysing analogues, our tool saves valuable time and resources, enabling your team to focus on strategy and execution.

  • Comprehensive Insights:

    With access to both quantitative and qualitative data, our tool provides a holistic view of market dynamics, allowing for more informed decision-making.

  • Oncology-Specific Filters

    For those in oncology, our tool offers specific filters that allow for precise drilling down into product profiles, ensuring the most relevant data is always at your fingertips.

Whether you’re making critical “Go-No Go” decisions, planning for a launch, or managing a product through its lifecycle, our Analogue Tool is your indispensable companion in the journey towards market success.

‘The analogue library will save us a lot time – it is quite apparent that it has been developed and created by forecasters, which is a real benefit to me and a differentiator to other analogue solutions in the market.’

Get in touch

We continue to develop the therapy areas covered by our analogue libraries and welcome a conversation about your specific needs. 

Discover how we can transform your forecasting approach—get in touch for a free demo.

Thank you in advance for your message. We ask for your details so that we can respond to your query quickly and accurately.

Please click here to view our personal data protection policies.

more insights

Pharmaceutical forecasting models

Client-Focused Pharma Forecasting: Building Models that Shape Strategy

9th September 2024

In the pharmaceutical world, forecasting plays a crucial role in shaping strategy and ensuring market success. For decades J+D have been building custom forecasting models designed to meet the specific needs of our clients. This article highlights our expertise in pharma forecasting and our commitment to listening closely to our clients, understanding the evolving questions they face at each stage of the product lifecycle, and applying best practice forecasting principles to deliver models that effectively support their strategic goals.

Read more >
Forecasting Analogue Tool Header image

Introducing Our Cutting-Edge Analogue Tool: Forecasting with Precision and Insight

28th August 2024

In pharmaceutical forecasting, accurate data is crucial for strategic decision-making. Introducing our new Analogue Tool, meticulously designed by experts for forecasters. This tool features a comprehensive analogue library, providing up to 2,000 oncology analogues across 20 indications. It offers advanced filtering, patient-level data, and a user-friendly interface, ensuring precise and actionable insights. Whether in early-stage planning, launch readiness, or lifecycle management, our tool enhances forecast accuracy, transparency, and efficiency.

Read more >
Load More